{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:24:14Z","timestamp":1791221054186,"version":"4.1.0"},"reference-count":46,"publisher":"American Psychiatric Association Publishing","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[1999,8,1]]},"DOI":"10.1176\/ajp.156.8.1209","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:19:38Z","timestamp":1659097178000},"page":"1209-1215","source":"Crossref","is-referenced-by-count":199,"title":["High Midbrain [\n                    <sup>18<\/sup>\n                    F]DOPA Accumulation in Children With Attention Deficit Hyperactivity Disorder"],"prefix":"10.1176","volume":"156","author":[{"given":"Monique","family":"Ernst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Zametkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Matochik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Pascualvaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Jons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1568CIHJJJAJ","doi-asserted-by":"crossref","unstructured":"Castellanos FX, Elia J, Kruesi MJP, Marsh WL, Gulotta CS, Potter WZ, Ritchie GF, Hamburger SD, Rapoport JL: Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention-deficit\/hyperactivity disorder. Neuropsychopharmacology 1996; 14:125\u2013137","DOI":"10.1016\/0893-133X(95)00077-Q"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Shetty T, Chase TN: Central monoamines and hyperkinesis of childhood. Neurology 1976; 26:1000\u20131002","DOI":"10.1212\/WNL.26.10.1000"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Shaywitz BA, Cohen DJ, Bowers MBJ: CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine: a preliminary report. J Pediatr 1977; 90:67\u201371","DOI":"10.1016\/S0022-3476(77)80766-X"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Cohen DJ, Caparulo BK, Shaywitz BA, Bowers MB: Dopamine and serotonin metabolism in neuropsychiatrically disturbed children: CSF homovanillic acid and 5-hydroxyindoleacetic acid. Arch Gen Psychiatry 1977; 34:545\u2013550","DOI":"10.1001\/archpsyc.1977.01770170055004"},{"key":"atypb4","unstructured":"Shekim WO, Javaid J, Davis JM, Bylund DB: Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine. Biol Psychiatry 1983; 18:707\u2013714"},{"key":"atypb5","doi-asserted-by":"crossref","unstructured":"Ernst M, Liebenauer LL, Tebeka D, Jons PH, Eisenhofer G, Murphy DL, Zametkin AJ: Selegiline in ADHD adults: plasma monoamines and monoamine metabolites. Neuropsychopharmacology 1997; 16:276\u2013284","DOI":"10.1016\/S0893-133X(96)00243-6"},{"key":"R1568CIHEJIEB","doi-asserted-by":"crossref","unstructured":"Reimherr FW, Wender PH, Ebert MH, Wood DR: Cerebrospinal fluid homovanillic acid and 5-hydroxyindolacetic acid in adults with attention deficit hyperactivity disorder, residual type. Psychiatry Res 1984; 11:71\u201378","DOI":"10.1016\/0165-1781(84)90109-4"},{"key":"R1568CIHHIFIC","doi-asserted-by":"crossref","unstructured":"Aylward EH, Reiss AL, Reader MJ: Basal ganglia volumes in children with attention-deficit hyperactivity disorder. J Child Neurol 1996; 11:112\u2013115","DOI":"10.1177\/088307389601100210"},{"key":"atypb6","doi-asserted-by":"crossref","unstructured":"Castellanos FX, Giedd JN, Marsh WL: Quantitative brain magnetic resonance imaging in attention-deficit\/hyperactivity disorder. Arch Gen Psychiatry 1996; 53:607\u2013616","DOI":"10.1001\/archpsyc.1996.01830070053009"},{"key":"R1568CIHGJEEH","doi-asserted-by":"crossref","unstructured":"Hynd GW, Hern KL, Novey ES: Attention deficit hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 1993; 8:339\u2013347","DOI":"10.1177\/088307389300800409"},{"key":"R1568CIHHDJCI","doi-asserted-by":"crossref","unstructured":"Zametkin AJ, Nordahl TE, Gross M, King AC, Semple WE, Rumsey J, Hamburger S, Cohen RM: Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990; 323:1361\u20131366","DOI":"10.1056\/NEJM199011153232001"},{"key":"R1568CIHFFEDJ","doi-asserted-by":"crossref","unstructured":"Zametkin A, Liebenauer L, Fitzgerald G, King A, Minkunas D, Herscovitch P, Yamada E, Cohen R: Brain metabolism in teenagers with attention deficit hyperactivity disorder. Arch Gen Psychiatry 1993; 50:333\u2013340","DOI":"10.1001\/archpsyc.1993.01820170011002"},{"key":"R1568CIHIAJAC","doi-asserted-by":"crossref","unstructured":"Ernst M, Liebenauer LL, King AC, Fitzgerald GA, Cohen RM, Zametkin AJ: Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry 1994; 33:858\u2013868","DOI":"10.1097\/00004583-199407000-00012"},{"key":"R1568CIHFBCAE","unstructured":"Ernst M, Zametkin AJ, Matochik JA, Liebenauer L, Fitzgerald GA, Cohen RM: Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD): preliminary findings. Psychopharmacol Bull 1994; 30:219\u2013225"},{"key":"atypb7","doi-asserted-by":"crossref","unstructured":"Matochik JA, Nordahl TE, Gross M, Semple WE, King AC, Cohen RM, Zametkin AJ: Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity. Neuropsychopharmacology 1993; 8:377\u2013386","DOI":"10.1038\/npp.1993.38"},{"key":"atypb8","doi-asserted-by":"crossref","unstructured":"Matochik JA, Liebenauer LL, King C, Szymanski HV, Cohen RM, Zametkin AJ: Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment. Am J Psychiatry 1994; 151:658\u2013664","DOI":"10.1176\/ajp.151.5.658"},{"key":"R1568CIHGJHIG","doi-asserted-by":"crossref","unstructured":"Ernst M, Zametkin AJ, Matochik JA, Schmidt M, Liebenauer LL, Jons PH, Hardy K, Cohen RM: Intravenous dextroamphetamine and brain glucose metabolism. Neuropsychopharmacology 1997; 17:391\u2013401","DOI":"10.1016\/S0893-133X(97)00088-2"},{"key":"R1568CIHHIJEB","unstructured":"Cook EH, Stein MA, Krasowski MD: Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56:993\u2013998"},{"key":"R1568CIHJJHAI","unstructured":"LaHoste GJ, Swanson JM, Wigal SB: Dopamine D4 receptor gene polymorphisms associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1:121\u2013124"},{"key":"R1568CIHJFBGD","doi-asserted-by":"crossref","unstructured":"Cumming P, Gjedde A: Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse 1998; 29:37\u201361","DOI":"10.1002\/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO;2-C"},{"key":"R1568CIHDCIBB","doi-asserted-by":"crossref","unstructured":"Zametkin AJ, Schwartz DJ, Ernst ME, Cohen RM: Is research in normal and ill children involving radiation exposure ethical? (letter). Arch Gen Psychiatry 1996; 53:1060\u20131061","DOI":"10.1001\/archpsyc.1996.01830110098015"},{"key":"R1568CIHFFGIB","unstructured":"Ernst M, Freed ME, Zametkin AJ: Health hazards of radiation exposure in the context of brain imaging research: special consideration for children. J Nucl Med 1998; 39:689\u2013698"},{"key":"R1568CIHJBJHB","doi-asserted-by":"crossref","unstructured":"Goyette CH, Conners CK, Ulrich RF: Normative data on revised Conners parent and teacher rating scales. J Abnorm Child Psychol 1978; 6:221\u2013236","DOI":"10.1007\/BF00919127"},{"key":"R1568CIHDCFCB","unstructured":"Ullmann RK, Sleator EK, Sprague RL: Introduction to the use of ACTeRS. Psychopharmacol Bull 1985; 21:915\u2013920"},{"key":"R1568CIHCCGBC","doi-asserted-by":"crossref","unstructured":"Gershon ES, DeLisi LE, Hamovit J, Nurnberger JIJ, Maxell ME, Schreiber J, Dauphinais D, Dingman CWI, Guroff JJ: A controlled family study of chronic psychosis. Arch Gen Psychiatry 1988; 45:328\u2013336","DOI":"10.1001\/archpsyc.1988.01800280038006"},{"key":"R1568CIHHFDCE","doi-asserted-by":"crossref","unstructured":"McLellan C, Doudet D, Brucke T, Aigner T, Cohen R: New rapid analysis method demonstrates differences in 6-[18-F]Fluoro-L-DOPA plasma input curves with and without carbidopa in hemi-MPTP lesioned monkeys. Appl Radiat Isot 1991; 42:847\u2013854","DOI":"10.1016\/0883-2889(91)90223-N"},{"key":"R1568CIHJCJBA","unstructured":"Doudet DJ, McLellan CA, Aigner TG, Wyatt RJ, Cohen RM: Delayed L-phenylalanine infusion allows for simultaneous kinetic analysis and improved evaluation of specific-to-nonspecific fluorine-18-DOPA uptake in brain. J Nucl Med 1992; 33:1383\u20131389"},{"key":"R1568CIHIDIAC","doi-asserted-by":"crossref","unstructured":"Doudet DJ, Aigner TG, McLellan CA, Cohen RM: Positron emission tomography with 18-F-DOPA: interpretation and biological correlates in non-human primates. Psychiatry Res 1992; 45:153\u2013168","DOI":"10.1016\/0925-4927(92)90023-W"},{"key":"R1568CIHBGDBI","doi-asserted-by":"crossref","unstructured":"Ernst M, Zametkin A, Matochik J, Pascualvaca D, Jons P, Hardy K, Hankerson J, Doudet D, Cohen R: Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Engl J Med 1996; 334:1568\u20131604","DOI":"10.1056\/NEJM199606133342403"},{"key":"R1568CIHBFEDB","doi-asserted-by":"crossref","unstructured":"Torstenson R, Hartvig P, Langstrom B, Westerberg G, Tedroff J: Differential effects of levodopa on dopaminergic function in early and advanced Parkinson\u2019s disease. Ann Neurol 1997; 41:334\u2013440","DOI":"10.1002\/ana.410410308"},{"key":"R1568CIHJAAIE","doi-asserted-by":"crossref","unstructured":"Abercrombie ED, Bonatz AE, Zigmond MJ: Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 1990; 525:36\u201344","DOI":"10.1016\/0006-8993(90)91318-B"},{"key":"R1568CIHHBDGB","doi-asserted-by":"crossref","unstructured":"Zhu MY, Jurio AV, Paterson I, Boulton AA: Regulation of striatal L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors. Eur J Pharmacol 1993; 238:157\u2013164","DOI":"10.1016\/0014-2999(93)90843-7"},{"key":"R1568CIHFCFJG","doi-asserted-by":"crossref","unstructured":"Hadjiconstantinou M, Wemlinger TA, Sylvia CP, Hubble JP, Neff NH: Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors. J Neurochem 1993; 60:2175\u20132180","DOI":"10.1111\/j.1471-4159.1993.tb03503.x"},{"key":"R1568CIHFDBHG","doi-asserted-by":"crossref","unstructured":"Sivam SP: Dopaminergic regulation of postnatal development of dynorphin neurons in rat striatum. Neuropeptides 1996; 30:103\u2013107","DOI":"10.1016\/S0143-4179(96)90062-1"},{"key":"atypb9","doi-asserted-by":"crossref","unstructured":"Schmidt U, Beyer C, Oestreicher AB, Reisert I, Schilling K: Pilgrim C activation of dopaminergic D1 receptors promotes morphogenesis of developing striatal neurons. Neuroscience 1996; 74:453\u2013460","DOI":"10.1016\/0306-4522(96)00201-1"},{"key":"atypb10","doi-asserted-by":"crossref","unstructured":"Penit-Soria J, Durand C, Herve D, Besson MJ: Morphological and biochemical adaptations to unilateral dopamine denervation of the neostriatum in newborn rats. Neuroscience 1997; 77:753\u2013766","DOI":"10.1016\/S0306-4522(96)00500-3"},{"key":"atypb11","doi-asserted-by":"crossref","unstructured":"Levitt P, Harvey JA, Friedman E, Simansky K, Murphy EH: New evidence for neurotransmitter influences on brain development. Trends Neurosci 1997; 20:269\u2013274","DOI":"10.1016\/S0166-2236(96)01028-4"},{"key":"R1568CIHFHHID","doi-asserted-by":"crossref","unstructured":"Blanchard V, Anglade P, Dziewczapolski G, Savasta M, Agid Y, Raisman-Vozari R: Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra. Brain Res 1996; 19:319\u2013325","DOI":"10.1016\/0006-8993(95)01391-1"},{"key":"R1568CIHGFEEG","doi-asserted-by":"crossref","unstructured":"Alexander GE, Crutcher MD: Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990; 13:266\u2013271","DOI":"10.1016\/0166-2236(90)90107-L"},{"key":"R1568CIHFDAEC","doi-asserted-by":"crossref","unstructured":"Gerfen CR: The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 1992; 15:133\u2013139","DOI":"10.1016\/0166-2236(92)90355-C"},{"key":"R1568CIHGBADB","doi-asserted-by":"crossref","unstructured":"Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Karoum F, Potter WZ, Ismond D: Treatment of hyperactive children with monoamine oxidase inhibitors. Arch Gen Psychiatry 1985; 42:969\u2013973","DOI":"10.1001\/archpsyc.1985.01790330049006"},{"key":"R1568CIHECGJF","doi-asserted-by":"crossref","unstructured":"Trott GE, Friese HJ, Menzel M, Nissen G: Use of moclobemide in children with attention deficit hyperactivity disorder. Psychopharmacology (Berl) 1992; 196:134\u2013136","DOI":"10.1007\/BF02246258"},{"key":"R1568CIHIFFGB","doi-asserted-by":"crossref","unstructured":"Voeller KKS, Heilman KM: Attention deficit disorder in children: a neglect syndrome? Neurology 1988; 38:806\u2013808","DOI":"10.1212\/WNL.38.5.806"},{"key":"atypb12","doi-asserted-by":"crossref","unstructured":"Malone MA, Kershner JR, Swanson JM: Hemispheric processing and methylphenidate effects in attention-deficit hyperactivity disorder. J Child Neurol 1994; 9:181\u2013189","DOI":"10.1177\/088307389400900216"},{"key":"atypb13","doi-asserted-by":"crossref","unstructured":"Gross-Tsur V, Shalev RS, Manor O, Amir N: Developmental right-hemisphere syndrome: clinical spectrum of the nonverbal learning disability. J Learn Disabil 1995; 28:80\u201386","DOI":"10.1177\/002221949502800202"},{"key":"R1568CIHCEBGF","doi-asserted-by":"crossref","unstructured":"Campbell L, Malone MA, Kershner JR, Roberts W, Humphries T, Logan WJ: Methylphenidate slows right hemisphere processing in children with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 1996; 6:229\u2013239","DOI":"10.1089\/cap.1996.6.229"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ajp.psychiatryonline.org\/doi\/10.1176\/ajp.156.8.1209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T09:04:49Z","timestamp":1722157489000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.156.8.1209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8,1]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1999,8,1]]}},"alternative-id":["10.1176\/ajp.156.8.1209"],"URL":"https:\/\/doi.org\/10.1176\/ajp.156.8.1209","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,8,1]]}}}